Balasingam Radhakrishnan
38Patents
10h-index
31Co-inventors
75Inventor score
Filing activity: Oct 27, 1997 → Oct 15, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6191105A | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin | Human Necessities | 77 | Expired |
| US7662773B2 | Natriuretic compounds, conjugates, and uses thereof | Chemistry; Metallurgy | 27 | Active |
| US6930090B2 | Methods of activating a receptor using amphiphilic drug-oligomer conjugates | Human Necessities | 20 | Expired |
| US7605123B2 | Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof | Human Necessities | 18 | Active |
| US6828297B2 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 15 | Expired |
| US7423014B2 | Insulin conjugates for treating diabetes mellitus | Human Necessities | 15 | Expired |
| US9217014B2 | Antifungal agents and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US9526835B2 | Dosing regimens for echinocandin class compounds | Human Necessities | 12 | Active |
| US9676821B2 | Antifungal agents and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US10016479B2 | Dosing regimens for echinocandin class compounds | Human Necessities | 11 | Active |
| US7084114B2 | Mixtures of insulin drug-oligomer comprising polyalkylene glycol | Human Necessities | 10 | Expired |
| US10702573B2 | Dosing regimens for echinocandin class compounds | Human Necessities | 8 | Active |
| US7875700B2 | Cation complexes of insulin compound conjugates, formulation and uses thereof | Human Necessities | 7 | Active |
| US7470663B2 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | Human Necessities | 7 | Expired |
| US6913903B2 | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | Human Necessities | 5 | Expired |
| US7872095B2 | Insulin-oligomer conjugates, formulations and uses thereof | Human Necessities | 4 | Active |
| US11197909B2 | Compositions and methods for the treatment of fungal infections | Human Necessities | 4 | Active |
| US11524980B2 | Synthesis of echinocandin antifungal agent | Human Necessities | 3 | Active |
| US7166571B2 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | Human Necessities | 2 | Expired |
| US11123319B2 | Methods and compositions for treating edema refractory to oral diuretics | Human Necessities | 1 | Active |
| US12150923B2 | Methods and compositions for treating edema refractory to oral diuretics | Human Necessities | 1 | Active |
| US11260038B1 | Methods and compositions for treating edema refractory to oral diuretics | Human Necessities | 1 | Active |
| US7713932B2 | Calcitonin drug-oligomer conjugates, and uses thereof | Human Necessities | 0 | Expired |
| US7312192B2 | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same | Human Necessities | 0 | Expired |
| US11654196B2 | Dosing regimens for echinocandin class compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.